Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichi Node

Showing results (671-680 of 717) with videos related to

Pageof 72
Sort By:
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 6, 2026
Epidemiological and clinical evidence on blood pressure management for the prevention of dementia: striving for a healthy 100-year lifeShintaro Ishida, Miki Kawazoe, Takako Fujii, et al.
JMA Journal|May 17, 2021
The Japanese Medical Science Federation COVID-19 Expert Opinion English VersionMasaomi Nangaku, Takashi Kadowaki, Hiroshi Yotsuyanagi, et al.
Cardiovascular Diabetology|April 14, 2017
Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trialAtsushi Tanaka, Michio Shimabukuro, Yosuke Okada, et al.
International Journal of Cardiology|November 21, 2021
Simple risk-score model for in-hospital major bleeding based on multiple blood variables in patients with acute myocardial infarctionYuhei Goriki, Goro Yoshioka, Masahiro Natsuaki, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 24, 2022
Effect of Novel Stratified Lipid Risk by "LDL-Window" and Flow-Mediated Dilation on the Prognosis of Coronary Artery Disease Using the FMD-J Study A DataShichiro Abe, Yasuo Haruyama, Gen Kobashi, et al.
Cardiovascular Diabetology|September 14, 2016
Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT studyAtsushi Tanaka, Toyoaki Murohara, Isao Taguchi, et al.
Plos Medicine|June 29, 2016
The Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled TrialJun-Ichi Oyama, Toyoaki Murohara, Masafumi Kitakaze, et al.
American Journal of Hypertension|May 5, 2022
Medication-Naïve Blood Pressure and Incident Cancers: Analysis of 2 Nationwide Population-Based DatabasesHidehiro Kaneko, Yuichiro Yano, Hyeok-Hee Lee, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 10, 2019
JSH Statement: Asahikawa declaration in promotion of diversity by the Japanese society of hypertension-the JSH Asahikawa declarationSatoko Nakamura, Naoyuki Hasebe, Midori Yatabe, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 13, 2018
The Japanese Society of Hypertension-Digest of plan for the futureKoichi Node, Takuya Kishi, Atsushi Tanaka, et al.
Pageof 72

Showing results (671-680 of 717) with videos related to

Sort By:
Pageof 72
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 6, 2026
Epidemiological and clinical evidence on blood pressure management for the prevention of dementia: striving for a healthy 100-year lifeShintaro Ishida, Miki Kawazoe, Takako Fujii, et al.
JMA Journal|May 17, 2021
The Japanese Medical Science Federation COVID-19 Expert Opinion English VersionMasaomi Nangaku, Takashi Kadowaki, Hiroshi Yotsuyanagi, et al.
Cardiovascular Diabetology|April 14, 2017
Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trialAtsushi Tanaka, Michio Shimabukuro, Yosuke Okada, et al.
International Journal of Cardiology|November 21, 2021
Simple risk-score model for in-hospital major bleeding based on multiple blood variables in patients with acute myocardial infarctionYuhei Goriki, Goro Yoshioka, Masahiro Natsuaki, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 24, 2022
Effect of Novel Stratified Lipid Risk by "LDL-Window" and Flow-Mediated Dilation on the Prognosis of Coronary Artery Disease Using the FMD-J Study A DataShichiro Abe, Yasuo Haruyama, Gen Kobashi, et al.
Cardiovascular Diabetology|September 14, 2016
Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT studyAtsushi Tanaka, Toyoaki Murohara, Isao Taguchi, et al.
Plos Medicine|June 29, 2016
The Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled TrialJun-Ichi Oyama, Toyoaki Murohara, Masafumi Kitakaze, et al.
American Journal of Hypertension|May 5, 2022
Medication-Naïve Blood Pressure and Incident Cancers: Analysis of 2 Nationwide Population-Based DatabasesHidehiro Kaneko, Yuichiro Yano, Hyeok-Hee Lee, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 10, 2019
JSH Statement: Asahikawa declaration in promotion of diversity by the Japanese society of hypertension-the JSH Asahikawa declarationSatoko Nakamura, Naoyuki Hasebe, Midori Yatabe, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 13, 2018
The Japanese Society of Hypertension-Digest of plan for the futureKoichi Node, Takuya Kishi, Atsushi Tanaka, et al.
Pageof 72